Clinical Trial Update: Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adjuvant cisplatin and docetaxel in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED